#OncoAlert COVID-19 round table discussions

The spread of novel betacoronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly escalated to a pandemic unseen for generations. With ramifications not before witnessed during peacetime, the medical community stands to face a very tough year.

Cancer patients represent a population at elevated risk for serious viral disease due to the immunosuppressive nature of both malignancy and anticancer treatments such as chemotherapy.1-3  Therefore, cancer patients may be at an increased risk of COVID-19 infection and henceforth face a poorer prognosis.

The OncoAlert network share what we know about the COVID-19 pandemic, specifically regarding cancer patients and the danger our colleagues are putting themselves in treating those infected (Part 2).

The OncoAlert network share what we know about the COVID-19 pandemic, specifically regarding cancer patients and the danger our colleagues are putting themselves in treating those infected (Part 1).

 

@OncoAlert hosts its 3rd round table discussion: Addressing health worker stress and health during the COVID-19 pandemic.

Speaking on the COVID-19 pandemic currently being battled worldwide, Gilberto Morgan, MD, PhD, of Skåne University Hospital, Lund, Sweden is joined by leading oncologists from across the globe in an #OncoAlert discussion.

 

OncoAlert Round Table The Italian COVID-19 Experience

References

  1. Reusser P. Management of viral infections in immunocompromised cancer patients. Swiss Medical Weekly. 2002;132:374–378.
  2. Sica A, Massarotti M. Myeloid suppressor cells in cancer and autoimmunity. J Autoimmun. 2017 Dec;85:117–125.
  3. Komada Y, Zhang SL, Zhou YW et al. Cellular immunosuppression in children with acute lymphoblastic leukemia: Effect of consolidation chemotherapy. Cancer Immunology. 1992;35:271–276.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter